Our Technology
Cutting-edge AI technology built on the world's largest IVUS dataset,
validated with clinical gold standards.
World's Largest IVUS Cohort
We trained our models on the world's largest labeled IVUS cohort, with 15 years of meticulously labeled data. This extensive dataset ensures robust and reliable AI performance across diverse clinical scenarios.
Cross-Validated with OCT and FFR
Our models have been trained and validated using cross-validation data with OCT and FFR, with over 600 cases. This multi-modal validation ensures clinical accuracy and reliability.
Real-World Edge Cases
Our dataset includes diverse edge cases from real-world procedures, not research cohorts. This includes stent underexpansion, malapposition, rupture, and many other complex clinical scenarios encountered in actual patient care.
Clinical Optimization by IVUS Leaders
Developed as a clinically optimized solution by IVUS leaders. Our CEO is a world-renowned expert who leads procedural consensus, ensuring our technology meets the highest clinical standards.
Internationally Patented Technology
Most of our technologies are protected by international patents. We have been developing AI for atherosclerosis for over a decade, and these technologies are registered as patents, ensuring innovation protection and competitive advantage.
IVUS Foundation Model
We possess a powerful IVUS foundation model. This not only improves model performance and maximizes inference efficiency, but also dramatically reduces the time required for additional labeling, enabling rapid adaptation to new clinical needs.